Inspire Medical Systems, Inc.
Inspire Medical Systems Announces $75M Accelerated Share Repurchase Transaction
Summary
On November 8, 2024, Inspire Medical Systems, Inc. announced an accelerated share repurchase (ASR) transaction with Goldman Sachs & Co. LLC. The transaction, valued at $75.0 million, is part of the Company's previously authorized $150.0 million share repurchase program. Under the ASR Agreement, the Company will repurchase shares of its common stock with an aggregate value of 80% of the repurchase price, based on the closing share price on November 8, 2024. The ASR transaction is expected to be completed by November 12, 2024, and is scheduled to terminate in the first quarter of 2025.
Profitelligence Alerts
Get alerts for INSP
Be first to know when Inspire Medical Systems, Inc. files with the SEC.
Filing Categories
Advertisement
About Inspire Medical Systems, Inc.
Inspire Medical Systems, Inc. is a pioneering company focused on developing and commercializing innovative medical technology designed to treat obstructive sleep apnea (OSA). The company's flagship product, the Inspire therapy, is an implantable neurostimulation device that provides a unique and effective solution for patients who are unable to utilize traditional continuous positive airway pressure (CPAP) devices. Inspire Medical Systems significantly impacts the healthcare sector by offering a less invasive, patient-friendly alternative to surgical treatments for OSA, improving quality of life for those affected by sleep disorders. Headquartered in Minnesota, Inspire Medical Systems continues to expand its presence within the medical device market, collaborating closely with hospitals and medical professionals to enhance sleep health management globally. This company's contributions underscore a growing focus on personalized and technologically advanced approaches to medical challenges, marking its importance in the evolving landscape of healthcare solutions.
Official SEC Documents
Advertisement